These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17537136)

  • 1. Ultrasound as an outcome measure to assess disease activity in disorders of skin thickening: an example of the use of radiologic techniques to assess skin disease.
    Bendeck SE; Jacobe HT
    Dermatol Ther; 2007; 20(2):86-92. PubMed ID: 17537136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on morphea: part II. Outcome measures and treatment.
    Fett N; Werth VP
    J Am Acad Dermatol; 2011 Feb; 64(2):231-42; quiz 243-4. PubMed ID: 21238824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 14-MHz ultrasonography as an outcome measure in morphea (localized scleroderma).
    Nezafati KA; Cayce RL; Susa JS; Setiawan AT; Tirkes T; Bendeck SE; Jacobe HT
    Arch Dermatol; 2011 Sep; 147(9):1112-5. PubMed ID: 21931057
    [No Abstract]   [Full Text] [Related]  

  • 4. 20-MHz B-mode ultrasound in monitoring the course of localized scleroderma (morphea).
    Hoffmann K; Gerbaulet U; el-Gammal S; Altmeyer P
    Acta Derm Venereol Suppl (Stockh); 1991; 164():3-16. PubMed ID: 1812687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practice gaps. The hard task of measuring cutaneous fibrosis: comment on "14-MHz ultrasonography as an outcome measure in morphea (localized scleroderma)".
    Lott JP; Girardi M
    Arch Dermatol; 2011 Sep; 147(9):1115-6. PubMed ID: 21931058
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diagnostic and therapeutic problems of scleroderma].
    Pogorzelska-Antkowiak A; Antkowiak R
    Wiad Lek; 2006; 59(5-6):392-5. PubMed ID: 17017489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sun Sign in the Ultrasound Diagnosis and Activity Assessment of Morphea.
    Salgueiro C; Baeza J; Moll C; Alfaro-Sepúlveda D; Mellado G; Villaseca-Hernández M; Vera-Kellet C; Wortsman X
    J Ultrasound Med; 2022 Jul; 41(7):1817-1824. PubMed ID: 34609755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphea and other localized forms of scleroderma.
    Vasquez R; Sendejo C; Jacobe H
    Curr Opin Rheumatol; 2012 Nov; 24(6):685-93. PubMed ID: 23018858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of Doppler ultrasound to evaluate lesions of localized scleroderma.
    Li SC; Liebling MS
    Curr Rheumatol Rep; 2009 Jul; 11(3):205-11. PubMed ID: 19604465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [How I explore ... A cutaneous scleroderma using noninvasive methods].
    Fraiture AL; Henry F; Goffin V; Piérard GE
    Rev Med Liege; 2002 Mar; 57(3):179-82. PubMed ID: 12014268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New developments in localized scleroderma.
    Zulian F
    Curr Opin Rheumatol; 2008 Sep; 20(5):601-7. PubMed ID: 18698185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An extended high-frequency ultrasound protocol for assessing and quantifying of inflammation and fibrosis in localized scleroderma.
    Ranosz-Janicka I; Lis-Święty A; Skrzypek-Salamon A; Brzezińska-Wcisło L
    Skin Res Technol; 2019 May; 25(3):359-366. PubMed ID: 30638285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment options for localized scleroderma.
    Dutz J
    Skin Therapy Lett; 2000; 5(2):3-5. PubMed ID: 10751843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasound monitoring of childhood linear morphea.
    Pérez-López I; Garrido-Colmenero C; Ruiz-Villaverde R; Tercedor-Sánchez J
    Actas Dermosifiliogr; 2015 May; 106(4):340-2. PubMed ID: 25544015
    [No Abstract]   [Full Text] [Related]  

  • 15. Ultrasound Morphea Activity Scoring (US-MAS): Modified US-MAS.
    Wortsman X; Vera-Kellet C
    J Ultrasound Med; 2023 Oct; 42(10):2447-2450. PubMed ID: 37129178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease-specific quality indicators, guidelines and outcome measures in scleroderma.
    Valentini G; Matucci Cerinic M
    Clin Exp Rheumatol; 2007; 25(6 Suppl 47):159-62. PubMed ID: 18021523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric morphea.
    Browning JC
    Dermatol Clin; 2013 Apr; 31(2):229-37. PubMed ID: 23557652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and management of morphea and lichen sclerosus and atrophicus in children.
    Pope E; Laxer RM
    Pediatr Clin North Am; 2014 Apr; 61(2):309-19. PubMed ID: 24636648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Imaging subcutaneous atrophy in circumscribed scleroderma with 20 MHz B-scan ultrasound].
    Lévy JJ; Gassmüller J; Audring H; Brenke A; Albrecht-Nebe H
    Hautarzt; 1993 Jul; 44(7):446-51. PubMed ID: 8365879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphea profunda presenting as a neuromuscular mimic.
    Voermans NC; Pillen S; de Jong EM; Creemers MC; Lammens M; van Alfen N
    J Clin Neuromuscul Dis; 2008 Jun; 9(4):407-14. PubMed ID: 18525425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.